S.M. Robertson

1.9k total citations
46 papers, 1.4k citations indexed

About

S.M. Robertson is a scholar working on Ophthalmology, Public Health, Environmental and Occupational Health and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, S.M. Robertson has authored 46 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Ophthalmology, 14 papers in Public Health, Environmental and Occupational Health and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in S.M. Robertson's work include Ocular Surface and Contact Lens (14 papers), Allergic Rhinitis and Sensitization (8 papers) and Glaucoma and retinal disorders (7 papers). S.M. Robertson is often cited by papers focused on Ocular Surface and Contact Lens (14 papers), Allergic Rhinitis and Sensitization (8 papers) and Glaucoma and retinal disorders (7 papers). S.M. Robertson collaborates with scholars based in United States, China and Norway. S.M. Robertson's co-authors include Michael V.W. Bergamini, Theresa Landry, Emily Sullivan, Alan L. Weiner, Lewis H. Silver, Sushanta Mallick, Russell Andrew, Peter A. Netland, Alberta A. Davis and John J. Cebra and has published in prestigious journals such as Nucleic Acids Research, Gut and International Journal of Molecular Sciences.

In The Last Decade

S.M. Robertson

44 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S.M. Robertson United States	20	799	452	426	226	199	46	1.4k
Wendy R. Kam United States	22	301 0.4×	783 1.7×	438 1.0×	74 0.3×	191 1.0×	47	1.3k
Brad Harten United States	9	83 0.1×	121 0.3×	134 0.3×	266 1.2×	264 1.3×	10	895
Philip R. B. McMaster United States	17	141 0.2×	67 0.1×	179 0.4×	326 1.4×	156 0.8×	40	843
Y. Shimomura Japan	16	243 0.3×	153 0.3×	192 0.5×	56 0.2×	178 0.9×	45	754
Alicia Y. W. Wong Singapore	12	160 0.2×	140 0.3×	39 0.1×	387 1.7×	318 1.6×	22	952
H. Anne Pereira United States	23	26 0.0×	107 0.2×	89 0.2×	580 2.6×	577 2.9×	47	1.4k
Raghuram Koganti United States	16	116 0.1×	141 0.3×	149 0.3×	117 0.5×	212 1.1×	36	764
Arun H. Patil India	17	71 0.1×	87 0.2×	60 0.1×	101 0.4×	511 2.6×	36	903
Marcelo Nociari United States	13	63 0.1×	57 0.1×	32 0.1×	413 1.8×	447 2.2×	18	1.2k

Countries citing papers authored by S.M. Robertson

Since Specialization

Citations

This map shows the geographic impact of S.M. Robertson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.M. Robertson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.M. Robertson more than expected).

Fields of papers citing papers by S.M. Robertson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.M. Robertson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.M. Robertson. The network helps show where S.M. Robertson may publish in the future.

Co-authorship network of co-authors of S.M. Robertson

This figure shows the co-authorship network connecting the top 25 collaborators of S.M. Robertson. A scholar is included among the top collaborators of S.M. Robertson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S.M. Robertson. S.M. Robertson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Korenfeld, Michael, S.M. Robertson, Jerry Stein, et al.. (2021). Topical lipoic acid choline ester eye drop for improvement of near visual acuity in subjects with presbyopia: a safety and preliminary efficacy trial. Eye. 35(12). 3292–3301. 35 indexed citations

Lichtenstein, Steven J., et al.. (2007). Safety and Tolerability of Olopatadine 0.2% in Children and Adolescents. Journal of Ocular Pharmacology and Therapeutics. 23(4). 366–371. 9 indexed citations

Robertson, S.M., et al.. (2007). A Novel In Vivo Rabbit Model that Mimics Human Dosing to Determine the Distribution of Antibiotics in Ocular Tissues. Journal of Ocular Pharmacology and Therapeutics. 23(4). 335–342. 21 indexed citations

Scoper, Stephen V., Gregg J. Berdy, Steven J. Lichtenstein, et al.. (2007). Perception and quality of life associated with the use of olopatadine 0.2% (Pataday™) in patients with active allergic conjunctivitis. Advances in Therapy. 24(6). 1221–1232. 19 indexed citations

Slakter, Jason S., Janice A. Jerdan, Frances Kane, et al.. (2005). Baseline Characteristics of a Phase 3 Clinical Study of Anecortave Acetate 15 mg in Patients With Exudative Age–Related Macular Degeneration (AMD). Investigative Ophthalmology & Visual Science. 46(13). 1374–1374. 1 indexed citations

Schuman, Joel S., Grégory Katz, Richard A. Lewis, et al.. (2005). Efficacy and Safety of a Fixed Combination of Travoprost 0.004%/Timolol 0.5% Ophthalmic Solution Once Daily for Open-Angle Glaucoma or Ocular Hypertension. American Journal of Ophthalmology. 140(2). 242.e1–242.e11. 76 indexed citations

Abelson, Mark B., Paul J Gomes, Robert D. Gross, et al.. (2004). Clinical efficacy of olopatadine hydrochloride ophthalmic solution 0.2% compared with placebo in patients with allergic conjunctivitis or rhinoconjunctivitis: a randomized, double-masked environmental study. Clinical Therapeutics. 26(8). 1237–1248. 28 indexed citations

Robertson, S.M., et al.. (2004). Absorption and Distribution of Moxifloxacin, Ofloxacin and Gatifloxacin into Ocular Tissues and Plasma Following Topical Ocular Administration to Pigmented Rabbits.. Investigative Ophthalmology & Visual Science. 45(13). 4906–4906. 2 indexed citations

Dubiner, Harvey, Theresa Landry, Michael V.W. Bergamini, et al.. (2004). Comparison of the diurnal ocular hypotensive efficacy of travoprost and latanoprost over a 44-hour period in patients with elevated intraocular pressure. Clinical Therapeutics. 26(1). 84–91. 74 indexed citations

10.

Robertson, S.M., et al.. (2003). Design of a Specialized Cannula for Posterior Juxtascleral Delivery of Anecortave Acetate to the Retina for Treatment CNV Associated with Age-Related Macular Degeneration (AMD). Investigative Ophthalmology & Visual Science. 44(13). 5036–5036.

11.

Gomes, Paul J, et al.. (2003). Olopatadine is Effective for the Prevention and Treatment of the Signs and Symptoms of Allergic Conjunctivitis. Investigative Ophthalmology & Visual Science. 44(13). 3737–3737. 3 indexed citations

12.

Robertson, S.M., et al.. (2003). Penetration and Distribution of Moxifloxacin and Ofloxacin into Ocular Tissues and Plasma Following Topical Ocular Administration to Pigmented Rabbits. Investigative Ophthalmology & Visual Science. 44(13). 1454–1454. 5 indexed citations

13.

Abelson, Mark B., et al.. (2003). Olopatadine Reduces Ocular Signs and Symptoms Associated With Allergic Conjunctivitis 16 Hours After Instillation. Investigative Ophthalmology & Visual Science. 44(13). 3736–3736. 3 indexed citations

14.

Netland, Peter A., S.M. Robertson, Emily Sullivan, et al.. (2003). Response to travoprost in black and nonblack patients with open-angle glaucoma or ocular hypertension. Advances in Therapy. 20(3). 149–163. 32 indexed citations

15.

Yanni, John M., et al.. (1993). Effect of Lodoxamide on in vitro and in vivo Conjunctival Immediate Hypersensitivity Responses in Rats. International Archives of Allergy and Immunology. 101(1). 102–106. 26 indexed citations

16.

Donoso, Larry A., Dale S. Gregerson, Laura E. Smith, et al.. (1990). S-Antigen: preparation and characterization of site-specific monoclonal antibodies. Current Eye Research. 9(4). 343–355. 60 indexed citations

17.

Lausch, Robert N., et al.. (1989). Quantitation of purified monoclonal antibody needed to prevent HSV-1 induced stromal keratitis in mice. Current Eye Research. 8(5). 499–506. 28 indexed citations

18.

SundarRaj, Nirmala, et al.. (1987). Macular corneal dystrophy: immunochemical characterization using monoclonal antibodies.. PubMed. 28(10). 1678–86. 6 indexed citations

19.

Hamilton, Stanley R., David F. Keren, J. K. Boitnott, S.M. Robertson, & J. H. Yardley. (1980). Enhancement by cholera toxin of IgA secretion from intestinal crypt epithelium.. Gut. 21(5). 365–369. 7 indexed citations

20.

Cebra, John J., R. S. Kamat, Patricia J. Gearhart, S.M. Robertson, & J Tseng. (1976). The secretory IgA System of the Gut. Novartis Foundation symposium. 5–28. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact